BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9066029)

  • 1. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
    Woody MA; Krakauer T; Stiles BG
    Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of the histidine-to-tyrosine staphylococcal enterotoxin B mutant protein in C3H/HeJ mice.
    Savransky V; Pinelis D; Korolev S; Ionin B; Fegeding K
    Toxicon; 2004 Mar; 43(4):433-8. PubMed ID: 15051407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.
    Woody MA; Krakauer T; Ulrich RG; Stiles BG
    J Infect Dis; 1998 Apr; 177(4):1013-22. PubMed ID: 9534976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
    Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G
    Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.
    Lowell GH; Colleton C; Frost D; Kaminski RW; Hughes M; Hatch J; Hooper C; Estep J; Pitt L; Topper M; Hunt RE; Baker W; Baze WB
    Infect Immun; 1996 Nov; 64(11):4686-93. PubMed ID: 8890226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B.
    Nagaki M; Muto Y; Ohnishi H; Yasuda S; Sano K; Naito T; Maeda T; Yamada T; Moriwaki H
    Gastroenterology; 1994 Feb; 106(2):450-8. PubMed ID: 8299910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model.
    Choi JY; Shin S; Kim NY; Son WS; Kang TJ; Song DH; Yu CH; Hur GH; Jeong ST; Shin YK
    Toxicon; 2017 Jun; 131():68-77. PubMed ID: 28359755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.
    Lowell GH; Kaminski RW; Grate S; Hunt RE; Charney C; Zimmer S; Colleton C
    Infect Immun; 1996 May; 64(5):1706-13. PubMed ID: 8613381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic cytokine and chemokine responses in immunized mice challenged with staphylococcal enterotoxin B.
    Hudson Reichenberg LC; Garg R; Fernalld R; Bost KL; Piller KJ
    Toxicon; 2017 Jul; 133():82-90. PubMed ID: 28478060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent production of TH2-type cytokines and polyclonal B cell activation after chronic administration of staphylococcal enterotoxin B in mice.
    Florquin S; Amraoui Z; Goldman M
    J Autoimmun; 1996 Oct; 9(5):609-15. PubMed ID: 8933276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B.
    Fan H; Zhao L; Wang W; Yu F; Jing H; Yang Y; Zhang X; Zhao Z; Gou Q; Zhang W; Zou Q; Zhang J; Zeng H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2360338. PubMed ID: 38857905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.
    Varshney AK; Wang X; Scharff MD; MacIntyre J; Zollner RS; Kovalenko OV; Martinez LR; Byrne FR; Fries BC
    J Infect Dis; 2013 Dec; 208(12):2058-66. PubMed ID: 23922375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mortality and impaired clonal deletion after staphylococcal enterotoxin B injection in old mice: relation to cytokines and nitric oxide production.
    Kuschnaroff LM; Goebels J; Valckx D; Heremans H; Matthys P; Waer M
    Scand J Immunol; 1997 Nov; 46(5):469-78. PubMed ID: 9393629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock.
    Bean AG; Freiberg RA; Andrade S; Menon S; Zlotnik A
    Infect Immun; 1993 Nov; 61(11):4937-9. PubMed ID: 8406900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.
    LeClaire RD; Hunt RE; Bavari S
    Infect Immun; 2002 May; 70(5):2278-81. PubMed ID: 11953360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.
    Harris TO; Grossman D; Kappler JW; Marrack P; Rich RR; Betley MJ
    Infect Immun; 1993 Aug; 61(8):3175-83. PubMed ID: 8335347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of staphylococcal enterotoxin B in serum and culture supernatant with a capture enzyme-linked immunosorbent assay.
    Cook E; Wang X; Robiou N; Fries BC
    Clin Vaccine Immunol; 2007 Sep; 14(9):1094-101. PubMed ID: 17634506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.
    Inskeep TK; Stahl C; Odle J; Oakes J; Hudson L; Bost KL; Piller KJ
    Clin Vaccine Immunol; 2010 Aug; 17(8):1163-9. PubMed ID: 20554806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
    Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ
    Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.